On the Role of Brain Mineralocorticoid (Type I) and Glucocorticoid (Type II) Receptors in Neuroendocrine Regulation
- 1 January 1989
- journal article
- research article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 50 (2) , 117-123
- https://doi.org/10.1159/000125210
Abstract
Administrations of the glucocorticoid receptor antagonist (anti-glucocorticoid, RU38486) and the mineralocorticoid antagonist (anti-mineralocoritcoid, RU28318) followed by frequent, sequential blood sampling were employed to investigate the possible role the brain mineralocorticoid receptor (MR, type I) and glucocorticoid receptor (GR, type II) have in the regulation of basal and stress-induced adrenocortical secretion in the rat. The anti-mineralocorticoid and anti-glucocorticoid were administered subcutaneously (s.c.) at doses of 2.5 mg and 1.0 mg/100 g body weight, respectively. Both antagonists were also given intracerebroventricularly (i.c.v.) at a dose of 100 ng/rat. Under basal non-stressed conditions (a t the diurnal trough in the morning), injections of either saline, anti-glucocorticoid (s.c. or i.c.v.) or anti-mineralocorticoid (s.c.) did not have effect on the plasma corticosterone level. The anti-mineralocorticoid given intracerebroventricularly, however, caused an elevation of plasma corticosterone up to 60 min after the injection. Exposure of the rats to a novel environment resulted in a large increase in the plasma corticosterone level, which was slightly reduced in the rats treated with the anti-glucocorticoid. In vehicle-treated rats, the level returned to basal values at 90 min, while the anti-glucocorticoid-and anti-mineralocorticoid-treated groups, it remained elevated for prolonged periods. The present study thus shows that (1) the anti-glucocorticoid RU3846 via the brain GR has no effect on the basal plasma corticosterone level in the morning but interferes with a glucocorticoid negative feedback following stress and (2) the anti-mineralocorticoid RU28318 via the brain MR elevates the basal plasma corticosterone level and enhances adrenocortical secretion following stress. Accordingly, both antagonists caused prolonged adrenocortical secretion following stress. Such an effect caused by the anti-mineralocorticoid is probably due to an enhanced stress responsiveness resulting from a blockade of the limbic MR and that caused by the anti-glucocorticoid resulting from a blockade of GR involved in the termination of the stress response.This publication has 22 references indexed in Scilit:
- Mapping of Glucocorticoid Receptor Immunoreactive Neurons in the Rat Tel- and Diencephalon Using a Monoclonal Antibody against Rat Liver Glucocorticoid Receptor*Endocrinology, 1985
- Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*Journal of Clinical Endocrinology & Metabolism, 1985
- The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in ManJournal of Clinical Endocrinology & Metabolism, 1984
- Characteristics of corticosteroid inhibition of adrenocorticotrophin release from the anterior pituitary gland of the ratJournal of Endocrinology, 1984
- RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.Proceedings of the National Academy of Sciences, 1984
- The effect of the antimineralocorticoid RU 28318 on aldosterone biosynthesis in vitroJournal of Steroid Biochemistry, 1984
- Specificity of the Adrenal Steroid Receptor System in Rat Hippocampus*Endocrinology, 1982
- The Site of Inhibitory Action of a Natural (Corticosterone) and Synthetic Steroid (Dexamethasone) in the Hypothalamus-Pituitary-Adrenal AxisNeuroendocrinology, 1981
- Adrenal steroids and extinction behavior: Antagonism by progesterone, deoxycorticosterone and dexamethasone of a specific effect of corticosteroneLife Sciences, 1980
- THE SITE OF THE BLOCKING ACTION OF DEXAMETHASONE ON STRESS-INDUCED PITUITARY ACTH RELEASEJournal of Endocrinology, 1964